The purpose of this study is to evaluate the relative effectiveness and safety of Onyx stent compared to other (drug eluting stents) DES.
Study Type
OBSERVATIONAL
Enrollment
4,500
Stent thrombosis
As per Academic Research Consortium (ARC) standard, definite or probable stent thrombosis
Time frame: 1 year
All death
Time frame: 5 year
Cardiac death
Time frame: 5 year
Myocardial infarction
Time frame: 5 year
Composite event of death or myocardial infarction
Time frame: 5 year
Composite event of cardiac death or myocardial infarction
Time frame: 5 year
Composite event rate
death, myocardial infarction, target vessel revascularization
Time frame: 5 year
Target Vessel revascularization
Time frame: 5 year
Target Lesion revascularization
Time frame: 5 year
Stent thrombosis
Time frame: 5 year
Stroke
Time frame: 5 year
Procedural success
defined as less than 30% residual stenosis at the completion of procedure without death or Q wave myocardial infarction or urgent revascularization participants will be followed for the duration of hospital stay, an expected average of 3days.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
The Catholic University of Korea, Yeouido St. Mary's Hospital
Seoul, Republic of Korea, South Korea
Asan Medical Center
Seoul, Songpa-gu, South Korea
Hallym University Sacred Heart Hospital
Anyang, South Korea
Soon Chun Hyang University Hospital Bucheon
Bucheon-si, South Korea
Soon Chun Hyang University Hospital Cheonan
Cheonan, South Korea
Gangwon National Univ. Hospital
Chuncheon, South Korea
Daegu Catholic University Medical Center
Daegu, South Korea
Keimyung University Dongsan Medical Center
Daegu, South Korea
Chungnam National University Hospital
Daejeon, South Korea
The Catholic University of Korea, Daejeon ST. Mary's Hospital
Daejeon, South Korea
...and 21 more locations
Time frame: 3 day